Overview and Applications of Nanocarrier-Based Drug Delivery for Alleviating Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss caused by the degeneration of neurons and the accumulation of amyloid plaques and tau tangles in the brain. The exact etiology of AD remains unclear, although both genetic and envi...
Saved in:
| Main Authors: | Sara Khan, Md. Faheem Haider, Nazish Naseem |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Association for the Advancement of Science (AAAS)
2025-01-01
|
| Series: | Journal of Bio-X Research |
| Online Access: | https://spj.science.org/doi/10.34133/jbioxresearch.0042 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanocarrier-based targeted drug delivery for Alzheimer’s disease: addressing neuroinflammation and enhancing clinical translation
by: Kang Wang, et al.
Published: (2025-05-01) -
Chitosan and Its Derivatives as Nanocarriers for Drug Delivery
by: Ranu Biswas, et al.
Published: (2025-03-01) -
The Pharmaceutical and Pharmacological Potential Applications of Bilosomes as Nanocarriers for Drug Delivery
by: Darko Mitrović, et al.
Published: (2025-03-01) -
Zein-Based Nanocarriers: Advances in Oral Drug Delivery
by: Yuxin Liu, et al.
Published: (2025-07-01) -
A review of saponin-based nanocarriers for drug delivery
by: Pathy B. Lokole, et al.
Published: (2025-01-01)